Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EOLS

Evolus

$14.72

-1.78 (-10.79%)

06:34
10/11/18
10/11
06:34
10/11/18
06:34
Recommendations
Evolus analyst commentary at Mizuho »

Evolus pulled back on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

Over a week ago
EOLS

Evolus

$17.89

0.57 (3.29%)

04:55
09/28/18
09/28
04:55
09/28/18
04:55
Conference/Events
Evolus management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 01

    Oct

  • 02

    Feb

APPF

AppFolio

$79.90

-2.25 (-2.74%)

, DCPH

Deciphera

$38.38

0.115 (0.30%)

08:30
09/27/18
09/27
08:30
09/27/18
08:30
Options
Seven new option listings on September 27th »

New option listings for…

APPF

AppFolio

$79.90

-2.25 (-2.74%)

DCPH

Deciphera

$38.38

0.115 (0.30%)

EOLS

Evolus

$17.32

-0.62 (-3.46%)

FSB

Franklin Financial Network

$39.55

-0.65 (-1.62%)

MESA

Mesa Air

$13.62

1.055 (8.40%)

PAR

PAR Technology

$21.75

-1.37 (-5.93%)

PRQR

ProQR Therapeutics

$18.75

-0.65 (-3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 01

    Oct

  • 27

    Nov

  • 02

    Feb

EOLS

Evolus

$17.32

-0.62 (-3.46%)

06:37
09/27/18
09/27
06:37
09/27/18
06:37
Conference/Events
Evolus management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 01

    Oct

  • 02

    Feb

EOLS

Evolus

$18.70

-2.45 (-11.58%)

, AGN

Allergan

$184.28

-3.91 (-2.08%)

07:22
09/18/18
09/18
07:22
09/18/18
07:22
Recommendations
Evolus, Allergan, Revance analyst commentary at Cantor Fitzgerald »

Evolus selloff yesterday…

EOLS

Evolus

$18.70

-2.45 (-11.58%)

AGN

Allergan

$184.28

-3.91 (-2.08%)

RVNC

Revance

$23.50

-2.15 (-8.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 27

    Sep

  • 01

    Oct

  • 27

    Nov

  • 02

    Feb

Over a month ago
EOLS

Evolus

$20.23

0.22 (1.10%)

08:18
08/29/18
08/29
08:18
08/29/18
08:18
Hot Stocks
Evolus announces acceptance of FDA BLA resubmission for prabotulinumtoxinA »

Evolus announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOLS

Evolus

$18.83

-0.29 (-1.52%)

08:04
08/17/18
08/17
08:04
08/17/18
08:04
Hot Stocks
Evolus announces Health Canada approval of DWP-450 »

Evolus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOLS

Evolus

$18.86

-0.43 (-2.23%)

, AGN

Allergan

$185.32

1.36 (0.74%)

14:42
08/02/18
08/02
14:42
08/02/18
14:42
Recommendations
Evolus, Allergan analyst commentary at JMP Securities »

Evolus price target…

EOLS

Evolus

$18.86

-0.43 (-2.23%)

AGN

Allergan

$185.32

1.36 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EOLS

Evolus

$19.29

-0.34 (-1.73%)

07:43
08/02/18
08/02
07:43
08/02/18
07:43
Earnings
Breaking Earnings news story on Evolus »

Evolus reports Q2 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EOLS

Evolus

$19.29

-0.34 (-1.73%)

07:27
08/02/18
08/02
07:27
08/02/18
07:27
Hot Stocks
Evolus announces early resubmission to FDA of BLA for DWP-450 »

Evolus announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.